Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 258.11M | 213.07M | 311.71M | 305.70M | 424.15M |
Total Receivables | 77.03M | 64.90M | 63.72M | 59.41M | 57.45M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.63M | 7.07M | 7.29M | 7.36M | 7.74M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 11.81M | 41.51M | 16.39M | 14.05M | 18.50M |
Total Current Assets | 353.57M | 326.54M | 399.10M | 386.51M | 507.85M |
|
|||||
Total Current Assets | 353.57M | 326.54M | 399.10M | 386.51M | 507.85M |
Net Property, Plant & Equipment | 111.72M | 113.69M | 103.59M | 97.12M | 95.62M |
Long-term Investments | 22.06M | 22.06M | 22.06M | 22.06M | 22.06M |
Goodwill | 22.06M | 22.06M | 22.06M | 22.06M | 22.06M |
Total Other Intangibles | 134.98M | 137.12M | 138.97M | 140.99M | 143.05M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.37M | 7.21M | 6.92M | 22.28M | 22.75M |
Total Assets | 1.22B | 1.23B | 1.23B | 1.23B | 1.24B |
|
|||||
Total Accounts Payable | 18.36M | 19.81M | 19.87M | 19.62M | 15.36M |
Total Accrued Expenses | 22.44M | 21.93M | 23.65M | 22.47M | 26.24M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.25M | 2.34M | 3.19M | 3.87M | 5.68M |
Total Finance Division Other Current Liabilities | 29.84M | 29.91M | 29.04M | 30.00M | 25.74M |
Total Other Current Liabilities | 29.84M | 29.91M | 29.04M | 30.00M | 25.74M |
Total Current Liabilities | 72.90M | 73.99M | 75.75M | 75.95M | 73.02M |
|
|||||
Total Current Liabilities | 72.90M | 73.99M | 75.75M | 75.95M | 73.02M |
Long-Term Debt | 2.49M | 2.49M | 2.49M | 2.49M | 2.96M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 4.48M | 5.11M | 7.69M | 7.20M | 7.91M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 10.93M | 17.27M | 17.46M | 17.60M | 18.15M |
Total Liabilities | 90.81M | 98.87M | 103.39M | 103.24M | 102.04M |
|
|||||
Common Stock & APIC | 543.13M | 532.91M | 522.42M | 511.33M | 501.72M |
Retained Earnings | 590.47M | 596.36M | 611.00M | 619.71M | 633.18M |
Treasury Stock & Other | -368.00K | 9.18M | -877.00K | -1.10M | 1.21M |
Total Common Equity | 1.13B | 1.14B | 1.13B | 1.13B | 1.14B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 1.13B | 1.14B | 1.13B | 1.13B | 1.14B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -4.07M | -3.55M | -3.70M | -3.30M | -2.82M |
Total Equity | 1.13B | 1.13B | 1.13B | 1.13B | 1.13B |
|